Elon Musk's brain-implant company Neuralink on Thursday said it had received US Food and Drug Administration's (FDA) approval to launch first-in-human clinical study.
Neuralink is developing a brain implant it hopes will help paralyzed people walk again and cure other neurological ailments.
Elon Musk's brain-implant company Neuralink on Thursday said it had received US Food and Drug Administration's approval to launch first-in-human clinical study. Several times since 2019, billionaire Elon Musk has predicted his brain-chip company would soon secure FDA approval for human trials. But the company's application was rejected in early 2022, and the company was working through the agency's concerns over the safety of the experimental implant.
"This is the result of incredible work by the Neuralink team in close collaboration with the FDA and represents an important first step that will one day allow our technology to help many people," Neuralink said in a tweet on Thursday.Neuralink is developing a brain implant it hopes will help paralyzed people walk again and cure other neurological ailments.
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
Elon Musk’s Neuralink gets US FDA approval for human clinical study of brain implantsElon Musk’s brain-implant company Neuralink on Thursday, May 25, said it had received the approval of the US Food and Drug Administration to launch a first-in-human clinical study. | Reuters
Baca lebih lajut »
DOH eyes one-jab vax vs papillomavirusThe DOH wants to shift to a single dose from its usual two-dose vaccine in its inoculation campaign against the cancer-causing human papillomavirus to make implementation more efficient and raise uptake rates. | kdevillaINQ /PDI
Baca lebih lajut »
Elon Musk’s Neuralink gets US FDA approval for human clinical study of brain implantsElon Musk’s brain-implant company Neuralink on Thursday, May 25, said it had received the approval of the US Food and Drug Administration to launch a first-in-human clinical study. | Reuters
Baca lebih lajut »
Miley Cyrus opens up about carrying 'guilt and shame' over past controversiesMiley Cyrus opened up about having carried 'guilt and shame' in her life because of the many controversies that surrounded her in her yesteryears. | via philstarlife
Baca lebih lajut »
Senate eyes approval of Maharlika bill by June 2Opposition Senator Risa Hontiveros said that 'immediate passage of the Maharlika Fund is too convoluted and vague.'
Baca lebih lajut »
DOH eyes one-jab vax vs papillomavirusThe DOH wants to shift to a single dose from its usual two-dose vaccine in its inoculation campaign against the cancer-causing human papillomavirus to make implementation more efficient and raise uptake rates. | kdevillaINQ /PDI
Baca lebih lajut »